Prognostic Significance of Immunohistochemical Expression of EGFR and C-erbB-2 Oncoprotein in Curatively Resected Gastric Cancer

참고문헌 (25)

1. "Annual report on the causeof death statistics( based on vital registration)", pp.14~15 (2001), Korea National Statistical Office
2. "Cancer incidencein Daegu in 1997-1998:the first results of the SDaeguCancer Registry", 33, pp.136~148 (2001)
3. "Cancer registrysystem in Korea. Available from: URL: http:"[DOI]
4. "Clinical significanceof epidermal growth factor receptor content in gastriccancer", 16, pp.183~188 (2001)
5. "Impact of epifermalgrowth factor(EGF)radioreceptor analysis on long-termsurvival of gastric cancer patients", 22, pp.1161~1167 (2002)
6. "Status of c-erbB-2 in gastricadenocarcinoma:a comparative study of immunohistochemistry,fluorescence in situ hybridization and enzyme- linkedimmunosorbennt assay", 98, pp.833~837 (2002)
7. "Phase II study ofweekly intravenous trastuzumab (Herceptin) in patients withHER2", neu-overexpressing metastatic breast cancer, 1999, pp.26, 78~83
8. "AJCC cancer stagingmanual", pp.71~76 (1997), Lippincott-Raven
9. "Nonparametric estimation for incompleteobservations", 53, pp.457~481 (1958)
10. "Statistical aspects of the analysis ofdata from retrospective studies of disease", 22, pp.719~748
11. "Regression models and life tables", 34, pp.187~220
12. "Clinical significance of epidermal growth factor and c-erbB-2 in human gastric cancer", 75, pp.1418~1425 (1995)
13. "Post-translational control of c-erbB-2 overexpression in stomach cancer cells", 33, pp.15~19 (2001)
14. "Amplification andoverexpression of the EGF receptor and C-erbB-2 proto- oncogenesin human stomach cancer", 64, pp.79~83 (1991)
15. "Relationship of p53 and c-erbB-2expression to histological features.Helicobacter pylori infection and prognosis in gastric cancer", 44, pp.604~609 (1997)
16. "Evaluation of immunoreactivity for erbB-2 protein as a markerof poor short term prognosis in gastric cancer", 51, pp.1034~1038
17. "DNA ploidy, proliferative index and EGF-R status in130 cases of resected gastric cancer- a multivariate analysis", 44, pp.826~837 (1997)
18. "c-erbB-2 oncogene product staining ingastric adenocarcinoma", 159, pp.107~111 (1989)
19. "Geneticalterations of the c-erb2 oncogene occur frequently in tubularadenocarcinoma of the stomach and are often accompanied byamplification of the v-erbA homologue", 2, pp.283~287 (1988)
20. "erbB-2 expression in well-differentiated adenocarcinoma ofthe stomach predicts shorter survival after curative resection", 115, pp.349~354 (1994)
21. "Increased estrogen receptorand epidermal growth factor receptor gene product co- expressionin surgically resected gastric adenocarcinomas", 63, pp.166~171 (1996)
22. "Comparative study oftumor angiogenesis and immunohistochemistry for p53,c-ErbB2,c-myc and EGFr as prognostic factors in gastric cancer", 15, pp.455~462 (2000)
23. "Relationship of C-erbB-2 protein expression and gene amplificationto invasion and metastasis in human gastric cancer", 72, pp.2083~2088 (1993)
24. "The prognostic significanceof c-erbB-2 and p53 protein expressions in gastriccarcinoma-a multivariate analysis of prognostic factors", 9, pp.248~253 (1994)
25. "Immunohistochemical detection of p53 protein,c-erbB-2 protein,epidermal growth factor receptor protein andproliferating cell nuclear antigen in gastric carcinoma", 8, pp.293~304 (1993)

관련 논문AI추천